|
⚲
|
| Keyboard |
| Zomedica Pharmaceuticals Corp | |
|---|---|
| Ticker | ZOMDF |
| CIK # | 0001684144 |
| CUSIP | 98980M109 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 100 Phoenix Drive Suite 190, Ann Arbor, MI 48108 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Zomedica Pharmaceuticals Corp | 2020-02-14 | Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001684144] | 10-K | |
| [0001684144] | 10-Q | |
| [0001684144] | 3 | |
| [0001684144] | 4 | |
| [0001684144] | 8-K | |
| [0001684144] | D | |
| [0001684144] | SC 13D | |
| [0001684144] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Whelan Sean
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,975,033 | $0.00 | |
|
Powers Johnny D
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,823,107 | $0.00 | |
|
Nichols Pamela
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,823,107 | $0.00 | |
|
Macleod Christopher Ross
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,823,107 | $0.00 | |
|
Cohen Robert
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,823,107 | $0.00 | |
|
Williams Rodney James
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 1,975,033 | $0.00 | |
|
Rowe Jeffrey M
Stock Appreciation Right · derivative
|
2025-11-17 | Grant | 2,126,959 | $0.00 | |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-11-13 | Buy | 150,000 | $0.10 | 15,000 |
|
Klass Russell Kevin
Common Stock, without par value.
|
2025-11-10 | Buy | 120,000 | $0.10 | 12,000 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-11-07 | Buy | 5,000 | $0.10 | 500 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-11-06 | Buy | 253,007 | $0.08 | 20,241 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-12 | Buy | 745,341 | $0.04 | 29,814 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-12 | Buy | 250,000 | $0.04 | 10,000 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-11 | Buy | 250,000 | $0.04 | 10,000 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-11 | Buy | 250,000 | $0.04 | 10,000 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-11 | Buy | 60,723 | $0.04 | 2,429 |
|
Klass Russell Kevin
Common Stock, without par value
|
2025-08-08 | Buy | 500,000 | $0.04 | 20,000 |
|
DeHaan-Fullerton Karen
Options to buy Common Stock · derivative
|
2025-06-12 | Grant | 500,000 | $0.00 | |
|
Blair Anthony K
Options to buy Common Stock · derivative
|
2025-06-12 | Grant | 750,000 | $0.00 | |
|
Klass Russell Kevin
Options to buy Common Stock · derivative
|
2025-06-12 | Grant | 500,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 8 | 1,030,419 |
| 2025-12-31 | 7 | 1,239,600 |
| 2025-09-30 | 9 | 1,781,696 |
| 2025-06-30 | 11 | 5,195,834 |
| 2025-03-31 | 23 | 6,970,824 |
| 2024-12-31 | 94 | 91,949,362 |
| 2024-09-30 | 87 | 81,261,052 |
| 2024-06-30 | 98 | 84,573,222 |
| 2024-03-31 | 99 | 85,030,389 |
| 2023-12-31 | 94 | 88,871,006 |
| 2023-09-30 | 89 | 84,096,046 |
| 2023-06-30 | 94 | 97,387,713 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Corecap Advisors LLC | [2026-06-30] | SOLE | 0 | 4,800 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 86 | Prev | Page 1 | Next |